telbivudine has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bair, MJ; Cai, ZS; Chang, CW; Chen, CJ; Chen, MJ; Lin, CC; Lin, YS; Yu, HC | 1 |
| Law, ST; Lee, AS; Lee, MK; Li, KK; Tung, Y | 1 |
| Chang, CY; Chen, TB; Hsu, YC; Lin, JT; Mo, LR; Tseng, CM | 1 |
3 other study(ies) available for telbivudine and Neoplasms
| Article | Year |
|---|---|
Efficacy of telbivudine and entecavir against virus reactivation in HBeAg-patients undergoing chemotherapy.
Topics: Acute Kidney Injury; Adult; Aged; Antineoplastic Agents; Antiviral Agents; Female; Glomerular Filtration Rate; Guanine; Hepatitis B e Antigens; Humans; Kidney Function Tests; Male; Middle Aged; Neoplasms; Retrospective Studies; Telbivudine | 2020 |
Comparison of clinical efficacy and renal safety of telbivudine and entecavir in chronic hepatitis B patients receiving cytotoxic chemotherapy.
Topics: Aged; Antineoplastic Agents; Antiviral Agents; DNA, Viral; Female; Glomerular Filtration Rate; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kidney; Male; Middle Aged; Neoplasms; Retrospective Studies; Secondary Prevention; Telbivudine; Thymidine; Virus Activation | 2016 |
Comparative effectiveness of nucleos(t)ide analogues in chronic hepatitis B patients undergoing cytotoxic chemotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Cytotoxins; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Neoplasms; Retrospective Studies; Telbivudine; Tenofovir; Thymidine; Virus Activation; Young Adult | 2016 |